PortfoliosLab logoPortfoliosLab logo
PCVX vs. ZS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

PCVX vs. ZS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vaxcyte, Inc. (PCVX) and Zscaler, Inc. (ZS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

PCVX vs. ZS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PCVX
Vaxcyte, Inc.
25.94%-43.64%30.35%30.97%101.56%-10.46%1.61%
ZS
Zscaler, Inc.
-37.63%24.67%-18.57%98.00%-65.18%60.90%94.90%

Fundamentals

EPS

PCVX:

-$4.83

ZS:

-$0.43

Total Revenue (TTM)

PCVX:

$0.00

ZS:

$3.00B

Gross Profit (TTM)

PCVX:

-$4.99M

ZS:

$2.30B

EBITDA (TTM)

PCVX:

-$599.85M

ZS:

$56.95M

Returns By Period

In the year-to-date period, PCVX achieves a 25.94% return, which is significantly higher than ZS's -37.63% return.


PCVX

1D
5.73%
1M
-5.88%
YTD
25.94%
6M
61.33%
1Y
53.89%
3Y*
15.74%
5Y*
22.66%
10Y*

ZS

1D
2.21%
1M
-4.56%
YTD
-37.63%
6M
-53.18%
1Y
-29.30%
3Y*
6.29%
5Y*
-4.41%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Vaxcyte, Inc.

Zscaler, Inc.

Return for Risk

PCVX vs. ZS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCVX
PCVX Risk / Return Rank: 4747
Overall Rank
PCVX Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
PCVX Sortino Ratio Rank: 6969
Sortino Ratio Rank
PCVX Omega Ratio Rank: 6666
Omega Ratio Rank
PCVX Calmar Ratio Rank: 1919
Calmar Ratio Rank
PCVX Martin Ratio Rank: 1010
Martin Ratio Rank

ZS
ZS Risk / Return Rank: 1818
Overall Rank
ZS Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
ZS Sortino Ratio Rank: 1717
Sortino Ratio Rank
ZS Omega Ratio Rank: 1616
Omega Ratio Rank
ZS Calmar Ratio Rank: 2525
Calmar Ratio Rank
ZS Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCVX vs. ZS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vaxcyte, Inc. (PCVX) and Zscaler, Inc. (ZS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PCVXZSDifference

Sharpe ratio

Return per unit of total volatility

0.94

-0.64

+1.58

Sortino ratio

Return per unit of downside risk

1.54

-0.68

+2.22

Omega ratio

Gain probability vs. loss probability

1.19

0.90

+0.29

Calmar ratio

Return relative to maximum drawdown

-0.63

-0.53

-0.10

Martin ratio

Return relative to average drawdown

-1.49

-1.24

-0.25

PCVX vs. ZS - Sharpe Ratio Comparison

The current PCVX Sharpe Ratio is 0.94, which is higher than the ZS Sharpe Ratio of -0.64. The chart below compares the historical Sharpe Ratios of PCVX and ZS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


PCVXZSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.94

-0.64

+1.58

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.36

-0.08

+0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.35

-0.12

Correlation

The correlation between PCVX and ZS is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

PCVX vs. ZS - Dividend Comparison

Neither PCVX nor ZS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PCVX vs. ZS - Drawdown Comparison

The maximum PCVX drawdown since its inception was -76.22%, roughly equal to the maximum ZS drawdown of -76.41%. Use the drawdown chart below to compare losses from any high point for PCVX and ZS.


Loading graphics...

Drawdown Indicators


PCVXZSDifference

Max Drawdown

Largest peak-to-trough decline

-76.22%

-76.41%

+0.19%

Max Drawdown (1Y)

Largest decline over 1 year

-20.60%

-60.40%

+39.80%

Max Drawdown (5Y)

Largest decline over 5 years

-76.22%

-76.41%

+0.19%

Current Drawdown

Current decline from peak

-50.73%

-61.96%

+11.23%

Average Drawdown

Average peak-to-trough decline

-37.62%

-31.96%

-5.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.97%

26.13%

-15.16%

Volatility

PCVX vs. ZS - Volatility Comparison

The current volatility for Vaxcyte, Inc. (PCVX) is 11.40%, while Zscaler, Inc. (ZS) has a volatility of 14.01%. This indicates that PCVX experiences smaller price fluctuations and is considered to be less risky than ZS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


PCVXZSDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.40%

14.01%

-2.61%

Volatility (6M)

Calculated over the trailing 6-month period

33.47%

36.32%

-2.85%

Volatility (1Y)

Calculated over the trailing 1-year period

73.60%

46.18%

+27.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.02%

53.25%

+10.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

66.63%

57.02%

+9.61%

Financials

PCVX vs. ZS - Financials Comparison

This section allows you to compare key financial metrics between Vaxcyte, Inc. and Zscaler, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
815.75M
(PCVX) Total Revenue
(ZS) Total Revenue
Values in USD except per share items